13,840
Views
1
CrossRef citations to date
0
Altmetric
Canadian Tuberculosis Standards - 8th Edition

Chapter 7: Extra-pulmonary tuberculosis

, &

References

  • World Health Organization. Definitions and Reporting Framework for Tuberculosis–2013 Revision: updated December 2014 and January 2020. 2013. https://apps.who.int/iris/handle/10665/79199. Accessed March 2, 2022.
  • Public Health Agency of Canada. personal communication. 2020.
  • Vachon J, Gallant V, Siu W. Tuberculosis in Canada, 2016. Can Commun Dis Rep. 2018;44(3-4):75–81. doi:10.14745/ccdr.v44i34a01.
  • Aguado JM, Herrero JA, Gavaldá J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation. 1997;63(9):1278–1286. doi:10.1097/00007890-199705150-00015.
  • Russo RL, Dulley FL, Suganuma L, França IL, Yasuda MA, Costa SF. Tuberculosis in hematopoietic stem cell transplant patients: case report and review of the literature. Int J Infect Dis. 2010;14 Suppl 3:e187–e191. doi:10.1016/j.ijid.2009.08.001.
  • Dobler CC, Cheung K, Nguyen J, Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J. 2017;50(2):1700157. doi:10.1183/13993003.00157-2017.
  • Kingkaew N, Sangtong B, Amnuaiphon W, et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Int J Infect Dis. 2009;13(6):722–729. doi:10.1016/j.ijid.2008.11.013.
  • Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148(5):1292–1297. doi:10.1164/ajrccm/148.5.1292.
  • Leeds IL, Magee MJ, Kurbatova EV, et al. Site of Extrapulmonary Tuberculosis is Associated with HIV Infection. Clinical Infectious Diseases. 2012;55(1):75–81. doi:10.1093/cid/cis303.
  • Lau SK, Wei WI, Hsu C, Engzell UC. Efficacy of fine needle aspiration cytology in the diagnosis of tuberculous cervical lymphadenopathy. J Laryngol Otol. 1990;104(1):24–27. doi:10.1017/s0022215100111697.
  • Asimacopoulos EP, Berry M, Garfield B, et al. The diagnostic efficacy of fine-needle aspiration using cytology and culture in tuberculosis lymphadenitis. Int J Tuberc Lung Dis. 2010;14(1):93–98.
  • Polesky A, Grove W, Bhatia G. Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore). 2005;84(6):350–362. doi:10.1097/01.md.0000189090.52626.7a.
  • Menzies D, Wong T, eds. Canadian Tuberculosis Standards. 7th ed.. Chapter 7: Nonrespiratory Tuberculosis. Canadian Thoracic Society, Canadian Lung Association, Public Health Agency of Canada. Can Respir J. 2013;20(Suppl A):54A–64A.
  • Kohli M, Schiller I, Dendukuri N, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1:CD012768. doi:10.1002/14651858.CD012768.pub3.
  • Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med. 1 2003;167(5):723–5. doi:10.1164/rccm.2111019.
  • Ruan SY, Chuang YC, Wang JY, et al. Revisiting tuberculosis pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax. Sep 2012;67(9):822–827. doi:10.1136/thoraxjnl-2011-201363.
  • Seibert AF, Haynes J, Jr., Middleton R, Bass JB.Jr. Tuberculous pleural effusion. Twenty-year experience. Chest. Apr. 1991;99(4):883–886. doi:10.1378/chest.99.4.883.
  • Akhter N, Sumalani KK, Chawla D, Rizvi A. N. Comparison between the diagnostic accuracy of Xpert MTB/Rif assay and culture for pleural tuberculosis using tissue biopsy. ERJ Open Res. 2019;5(3):00065-2019. doi:10.1183/23120541.00065-2019.
  • Diacon AH, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J. 2003;22(4):589–591. doi:10.1183/09031936.03.00017103a.
  • Casalini AG, Mori PA, Majori M, et al. Pleural tuberculosis: medical thoracoscopy greatly increases the diagnostic accuracy. ERJ Open Res. 2018;4(1):00046-2017. doi:10.1183/23120541.00046-2017.
  • Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017;64(2):e1–e33. doi:10.1093/cid/ciw694.
  • Chan CH, Arnold M, Chan CY, Mak TW, Hoheisel GB. Clinical and pathological features of tuberculous pleural effusion and its long-term consequences. Respiration. 1991;58(3-4):171–175. doi:10.1159/000195921.
  • Kohli M, Schiller I, Dendukuri N, et al. Xpert((R)) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. 2018;8:CD012768. doi:10.1002/14651858.CD012768.pub2.
  • Jiang J, Yang J, Shi Y, et al. Head-to-head comparison of the diagnostic accuracy of Xpert MTB/RIF and Xpert MTB/RIF Ultra for tuberculosis: a meta-analysis. Infect Dis (Lond). 2020; 52(11):763–775. doi:10.1080/23744235.2020.1788222.
  • Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaitre N. Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol. 2011;49(5):1772–1776. doi:10.1128/jcm.02157-10.
  • Lang AM, Feris-Iglesias J, Pena C, et al. Clinical evaluation of the Gen-Probe Amplified Direct Test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol. 1998;36(8):2191–2194. doi:10.1128/JCM.36.8.2191-2194.1998.
  • Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM. Diagnostic accuracy of nucleic acid amplification tests for ­tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003;3(10):633–643. doi:10.1016/s1473-3099(03)00772-2.
  • Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–187. doi:10.1016/j.jinf.2009.06.011.
  • Bouchama A, Al-Kawi MZ, Kanaan I, et al. Brain biopsy in tuberculoma: the risks and benefits. Neurosurgery. 1991;28(3):405–409.
  • Rajshekhar V, Chandy MJ. CT-guided stereotactic surgery in the management of intracranial tuberculomas. Br J Neurosurg. 1993;7(6):665–671. doi:10.3109/02688699308995096.
  • Mohanty A, Santosh V, Anandh B, et al. Diagnostic efficacy of stereotactic biopsies in intracranial tuberculomas. Surg Neurol. 1999;52(3):252–257. discussion 257-8. doi:10.1016/s0090-3019(99)00089-0.
  • Bahr NC, Nuwagira E, Evans EE, ASTRO-CM Trial Team, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis. 2018;18(1):68–75. doi:10.1016/s1473-3099(17)30474-7.
  • Erdem H, Ozturk-Engin D, Elaldi N, et al. The microbiological diagnosis of tuberculosis meningitis: results of Haydarpasa-1 study. Clin Microbiol Infect. 2014;20(10):O600–8. doi:10.1111/1469-0691.12478.
  • Heemskerk AD, Donovan J, Thu DDA, et al. Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl-Neelsen stain, GeneXpert, and culture of cerebrospinal fluid.J Infect. 2018;77(6):509–515. doi:10.1016/j.jinf.2018.09.003.
  • Maiti S, Banerjee M, Das R. Down to the ground zero: Perspective from tissue diagnosis in neurological TB. International Journal of Clinical and Biomedical Research. 2020;6(2):25–29. doi:10.31878/ijcbr.2020.62.07.
  • Giouleme O, Paschos P, Katsaros M, et al. Intestinal tuberculosis: a diagnostic challenge-case report and review of the literature. Eur J Gastroenterol Hepatol. 2011;23(11):1074–1077. doi:10.1097/MEG.0b013e32834a9470.
  • Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med. 1969;281(20):1091–1094. doi:10.1056/nejm196911132812003.
  • Sanai FM, Bzeizi KI. Systematic review: tuberculosis peritonitis–presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22(8):685–700. doi:10.1111/j.1365-2036.2005.02645.x.
  • Chau TN, Leung VK, Wong S, et al. Diagnostic challenges of tuberculosis peritonitis in patients with and without end-stage renal failure. Clin Infect Dis. 2007;45(12):e141–e146. doi:10.1086/523727.
  • Yeh HF, Chiu TF, Chen JC, Ng CJ. Tuberculous peritonitis: analysis of 211 cases in Taiwan. Dig Liver Dis. 2012;44(2):111–117. doi:10.1016/j.dld.2011.08.020.
  • Que Y, Wang X, Liu Y, Li P, Ou G, Zhao W. Ultrasound-guided biopsy of greater omentum: an effective method to trace the origin of unclear ascites. Eur J Radiol. May 2009;70(2):331–335. doi:10.1016/j.ejrad.2008.01.036.
  • Vardareli E, Kebapci M, Saricam T, Pasaoglu O, Acikalin M. Tuberculous peritonitis of the wet ascitic type: clinical features and diagnostic value of image-guided peritoneal biopsy. Dig Liver Dis. 2004;36(3):199–204. doi:10.1016/j.dld.2003.10.016.
  • Chow KM, Chow VC, Szeto CC. Indication for peritoneal biopsy in tuberculous peritonitis. Am J Surg. 2003;185(6):567–573. doi:10.1016/s0002-9610(03)00079-5.
  • Kumar S, Bopanna S, Kedia S, et al. Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis. Intest Res. 2017;15(2):187–194. doi:10.5217/ir.2017.15.2.187.
  • Talib A, Bhatty S, Mehmood K, et al. GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019;17:100131 doi:10.1016/j.jctube.2019.100131.
  • Liu R, Li J, Tan Y, et al. Multicenter evaluation of the acid-fast bacillus smear, mycobacterial culture, Xpert MTB/RIF assay, and adenosine deaminase for the diagnosis of tuberculosis peritonitis in China. Int J Infect Dis. 2020;90:119–124. doi:10.1016/j.ijid.2019.10.036.
  • Bellam BL, Mandavdhare HS, Sharma K, et al. Utility of tissue Xpert-Mtb/Rif for the diagnosis of intestinal tuberculosis in patients with ileocolonic ulcers. Ther Adv Infect Dis. 2019;6:2049936119863939 doi:10.1177/2049936119863939.
  • Bera C, Michael JS, Burad D, et al. Tissue Xpert MTB/Rif assay is of limited use in diagnosing peritoneal tuberculosis in patients with exudative ascites. Indian J Gastroenterol. 2015;34(5):395–398. doi:10.1007/s12664-015-0599-7.
  • Horvath KD, Whelan RL. Intestinal tuberculosis: return of an old disease. Am J Gastroenterol. 1998;93(5):692–696. doi:10.1111/j.1572-0241.1998.207_a.x.
  • Penz E, Boffa J, Roberts DJ, et al. Diagnostic accuracy of the Xpert(R) MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis. Int j Tuberc Lung Dis. 2015;19(3):278–284. i-iii. doi:10.5588/ijtld.14.0262.
  • Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435–446. doi:10.1183/09031936.00007814.
  • Iseman M. A Clinician’s Guide to Tuberculosis. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
  • Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol. 2011;49(12):4138–4141. doi:10.1128/jcm.05434-11.
  • Bentz RR, Dimcheff DG, Nemiroff MJ, Tsang A, Weg JG. The incidence of urine cultures positive for Mycobacterium tuberculosis in a general tuberculosis patient population. Am Rev Respir Dis. 1975;111(5):647–650. doi:10.1164/arrd.1975.111.5.647.
  • Lattimer JK, Reilly RJ, Segawa A. The significance of the isolated positive urine culture in genitourinary tuberculosis. J Urol. 1969;102(5):610–613. doi:10.1016/s0022-5347(17)62211-0.
  • Hsu HL, Lai CC, Yu MC, et al. Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007. Eur J Clin Microbiol Infect Dis. 2011;30(3):319–326. doi:10.1007/s10096-010-1083-z.
  • Baniel J, Manning A, Leiman G. Fine needle cytodiagnosis of renal tuberculosis. J Urol. 1991;146(3):689–691. doi:10.1016/S0022-5347(17)37894-1.
  • Das KM, Vaidyanathan S, Rajwanshi A, Indudhara R. Renal tuberculosis: diagnosis with sonographically guided aspiration cytology. AJR Am J Roentgenol. 1992;158(3):571–573. doi:10.2214/ajr.158.3.1738997.
  • Turkmen IC, Bassullu N, Comunoglu C, et al. Female genital system tuberculosis: a retrospective clinicopathological study of 1,548 cases in Turkish women. Arch Gynecol Obstet. 2012;286(2):379–384. doi:10.1007/s00404-012-2281-y.
  • Margolis K, Wranz PA, Kruger TF, Joubert JJ, Odendaal HJ. Genital tuberculosis at Tygerberg Hospital–prevalence, clinical presentation and diagnosis. S Afr Med J. 1992;81(1):12–15.
  • Sharma JB, Kriplani A, Dharmendra S, Chaubey J, Kumar S, Sharma SK. Role of Gene Xpert in diagnosis of female genital tuberculosis: a preliminary report. Eur J Obstet Gynecol Reprod Biol. 2016;207:237–238. doi:10.1016/j.ejogrb.2016.10.045.
  • Thangappah RB, Paramasivan CN, Narayanan S. Evaluating PCR, culture & histopathology in the diagnosis of female genital tuberculosis. Indian J Med Res. 2011;134:40–46.
  • Gómez García I, Gómez Mampaso E, Burgos Revilla J, et al. Tuberculous orchiepididymitis during 1978-2003 period: review of 34 cases and role of 16S rRNA amplification. Urology. 2010;76(4):776–781. doi:10.1016/j.urology.2010.01.033.
  • Lee IK, Yang WC, Liu JW. Scrotal tuberculosis in adult patients: a 10-year clinical experience. Am J Trop Med Hyg. 2007;77(4):714–718.
  • Gorse GJ, Belshe RB. Male genital tuberculosis: a review of the literature with instructive case reports. Rev Infect Dis. 1985;7(4):511–524. Jul-Augdoi:10.1093/clinids/7.4.511.
  • Madeb R, Marshall J, Nativ O, Erturk E. Epididymal tuberculosis: case report and review of the literature. Urology. 2005;65(4):798. doi:10.1016/j.urology.2004.10.029.
  • Altez-Fernandez C, Ortiz V, Mirzazadeh M, Zegarra L, Seas C, Ugarte-Gil C. Diagnostic accuracy of nucleic acid amplification tests (NAATs) in urine for genitourinary tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2017;17(1):390. doi:10.1186/s12879-017-2476-8.
  • Chen Y, Wu P, Fu L, Liu YH, Zhang Y, Zhao Y. Multicentre evaluation of Xpert MTB/RIF assay in detecting urinary tract tuberculosis with urine samples. Sci Rep. 2019;9(1):11053. doi:10.1038/s41598-019-47358-3.
  • Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, Alcaide F. Evaluation of the Xpert MTB/RIF Ultra Assay for Direct Detection of Mycobacterium tuberculosis Complex in Smear-Negative Extrapulmonary Samples. J Clin Microbiol. 2018;56(9). doi:10.1128/JCM.00659-18.
  • Kashyap B, Kaur T, Jhamb R, Kaur I. Evaluating the utility of menstrual blood versus endometrial biopsy as a clinical sample in the diagnosis of female genital tuberculosis. Asian J Med Res. 2012;1:45–49.
  • Lenk S, Schroeder J. Genitourinary tuberculosis. Curr Opin Urol. 2001;11(1):93–98. doi:10.1097/00042307-200101000-00014.
  • Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P. Establishing the diagnosis of tuberculous vertebral osteomyelitis. Eur Spine J. 2013;22 Suppl 4:579–86. doi:10.1007/s00586.012-2348-2
  • Cormican L, Hammal R, Messenger J, Milburn HJ. Current difficulties in the diagnosis and management of spinal tuberculosis. Postgrad Med J. 2006;82(963):46–51. doi:10.1136/pgmj.2005.032862.
  • Garrido G, Gomez-Reino JJ, Fernandez-Dapica P, Palenque E, Prieto S. A review of peripheral tuberculosis arthritis. Semin Arthritis Rheum. 1988;18(2):142–149. doi:10.1016/0049-0172(88)90007-8.
  • Ellis ME, el-Ramahi KM, Al-Dalaan AN. Tuberculosis of peripheral joints: a dilemma in diagnosis. Tuber Lung Dis. 1993;74(6):399–404. doi:10.1016/0962-8479(93)90084-b.
  • Sant M, Bajaj H. Role of histopathology in the diagnosis of tuberculosis synovitis. J Indian Med Assoc. 1992;90(10):263–264.
  • Mondal A. Cytological diagnosis of vertebral tuberculosis with fine-needle aspiration biopsy. J Bone Joint Surg Am. 1994;76(2):181–184. doi:10.2106/00004623-199402000-00003.
  • Sun Q, Wang S, Dong W, et al. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. J Infect. 2019;79(2):153–158. doi:10.1016/j.jinf.2019.06.006.
  • Wallace R, Cohen AS. Tuberculous arthritis: A report of two cases with review of biopsy and synovial fluid findings. Am J Med. 1976;61(2):277–282. doi:10.1016/0002-9343(76)90177-7.
  • Pertuiset E, Beaudreuil J, Liote F, et al. Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore). 1999;78(5):309–320. doi:10.1097/00005792-199909000-00003.
  • Quale JM, Lipschik GY, Heurich AE. Management of tuberculous pericarditis. Ann Thorac Surg. 1987;43(6):653–655. doi:10.1016/s0003-4975(10)60243-3.
  • Strang JI, Kakaza HH, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculosis pericardial effusion in Transkei. Lancet. 1988;2(8614):759–764. doi:10.1016/S0140-6736(88)92415-4.
  • Komsuoğlu B, Göldelï O, Kulan K, Komsuoğlu SS. The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. Eur Heart J. 1995;16(8):1126–1130. doi:10.1093/oxfordjournals.eurheartj.a061057.
  • Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–3616. doi:10.1161/circulationaha.105.543066.
  • Fowler NO, Manitsas GT. Infectious pericarditis. Prog Cardiovasc Dis. 1973;16(3):323–336. doi:10.1016/S0033-0620(73)80004-0.
  • Trautner BW, Darouiche RO. Tuberculous pericarditis: optimal diagnosis and management. Clin Infect Dis. 2001;33(7):954–961. doi:10.1086/322621.
  • Cegielski JP, Devlin BH, Morris AJ. Comparison of PCR, culture, and histopathology for diagnosis of tuberculosis pericarditis. J Clin Microbiol. 1997;35(12):3254–7. doi:10.1128/JCM.35.12.3254–3257.1997
  • Yu G, Ye B, Chen D, et al. Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-gamma release assays for tuberculosis pericarditis using pericardial tissue. PLoS One. 2017;12(12):e0188704. doi:10.1371/journal.pone.0188704.
  • Prout S, Benatar SR. Disseminated tuberculosis. A study of 62 cases. S Afr Med J. 1980;58(21):835–842.
  • Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis. 1990;12(4):583–590. doi:10.1093/clinids/12.4.583.
  • Mert A, Bilir M, Tabak F, et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology. 2001;6(3):217–224. doi:10.1046/j.1440-1843.2001.00328.x.
  • Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med. 1990;89(3):291–296. doi:10.1016/0002-9343(90)90340-J.
  • Hussain SF, Irfan M, Abbasi M, et al. Clinical characteristics of 110 miliary tuberculosis patients from a low HIV prevalence country. Int J Tuberc Lung Dis. 2004;8(4):493–499.
  • Mert A, Arslan F, Kuyucu T, et al. Miliary tuberculosis: Epidemiologicaland clinical analysis of large-case series from moderate to low tuberculosis endemic Country. Medicine (Baltimore). 2017;96(5):e5875. doi:10.1097/MD.0000000000005875.
  • Sharma SK, Mohan A. Miliary Tuberculosis. Microbiol Spectr. 2017;5(2). doi:10.1128/microbiolspec.TNMI7-0013-2016.
  • Wang JY, Hsueh PR, Wang SK, et al. Disseminated tuberculosis: a 10-year experience in a medical center. Medicine (Baltimore). Jan 2007;86(1):39–46. doi:10.1097/MD.0b013e318030b605.
  • Dankner WM, Davis CE. Mycobacterium bovis as a significant cause of tuberculosis in children residing along the United States-Mexico border in the Baja California region. Pediatrics. 2000;105(6):E79–e79. doi:10.1542/peds.105.6.e79.
  • Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53(6):555–562. doi:10.1093/cid/cir454.
  • Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis. 1992;15(4):601–605. doi:10.1093/clind/15.4.601.
  • Cook VJ, Manfreda J, Hershfield ES. Tuberculous lymphadenitis in Manitoba: incidence, clinical characteristics and treatment. Can Respir J. 2004;11(4):279–286. doi:10.1155/2004/826501.
  • Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology. 2000;5(4):423–426. doi:10.1111/j.1440-1843.2000.00287.x.
  • Long R, Boffa J. High HIV-TB co-infection rates in marginalized populations: evidence from Alberta in support of screening TB patients for HIV. Can J Public Health. 2010;101(3):202–204.
  • Martin T, Hoeppner VH, Ring ED. Superficial mycobacterial lymphadenitis in Saskatchewan. CMAJ. 1988;138(5):431–434.
  • Metchock, BG, Nolte FS, and Wallace RJ. Jr. Manual of clinical microbiology. In: Mycobacterium. 7th ed. Washington, D.C.: American Society for Microbiology; 1999:399–437.
  • Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med. 1993;87(8):621–623. doi:10.1016/s0954-6111(05)80265-3.
  • Yuen AP, Wong SH, Tam CM, Chan SL, Wei WI, Lau SK. Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngol Head Neck Surg. 1997;116(2):189–192. doi:10.1016/s0194-5998(97)70323-1.
  • van Loenhout-Rooyackers JH, Laheij RJ, Richter C, Verbeek AL. Shortening the duration of treatment for cervical tuberculous lymphadenitis. Eur Respir J. 2000;15(1):192–195. doi:10.1183/09031936.00.15119200.
  • McMaster P, Isaacs D. Critical review of evidence for short course therapy for tuberculous adenitis in children. Pediatr Infect Dis J. 2000;19(5):401–404. doi:10.1097/00006454-200005000-00003.
  • Donald PR. The chemotherapy of tuberculous lymphadenopathy in children. Tuberculosis (Edinb). 2010;90(4):213–224. doi:10.1016/j.tube.2010.05.001.
  • Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis. 2005;40(9):1368–1371. doi:10.1086/429317.
  • Blaikley JF, Khalid S, Ormerod LP. Management of peripheral lymph node tuberculosis in routine practice: an unselected 10-year cohort. Int J Tuberc Lung Dis. 2011;15(3):375–378.
  • Seok H, Jeon JH, Oh KH, et al. Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis. BMC Infect Dis. 2019;19(1):867. doi:10.1186/s12879-019-4507-0.
  • Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusion. Respirology. Oct 2019;24(10):962–971. doi:10.1111/resp.13673.
  • Antonangelo L, Faria CS, Sales RK. Tuberculous pleural effusion: diagnosis & management. Expert Rev Respir Med. 2019;13(8):747–759. doi:10.1080/17476348.2019.1637737.
  • Wen P, Wei M, Han C, He Y, Wang MS. Risk factors for tuberculous empyema in pleural tuberculosis patients. Sci Rep. 2019;9(1):19569. doi:10.1038/s41598-019-56140-4.
  • Valdes L, Alvarez D, San JE, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998;158(18):2017–2021. doi:10.1001/archinte.158.18.2017.
  • Kim HJ, Lee HJ, Kwon SY, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest. 2006;129(5):1253–1258. doi:10.1378/chest.129.5.1253.
  • Ko JM, Park HJ, Kim CH. Pulmonary changes of pleural TB: up-to-date CT imaging. Chest. 2014;146(6):1604–1611. doi:10.1378/chest.14-0196.
  • Di Gennaro F, Pisani L, Veronese N, et al. Potential Diagnostic Properties of Chest Ultrasound in Thoracic Tuberculosis-A Systematic Review. IJERPH. Oct 12 2018;15(10):2235. doi:10.3390/ijerph15102235.
  • Keshishyan S, Kaul V, Gupta A, Ahn C, Aronow WS, Epelbaum O. Sputum culture for the diagnosis of tuberculous pleural effusion: analysis of absolute and incremental yields. Adv Respir Med. 2019;87(5):281–288. doi:10.5603/ARM.2019.0050.
  • Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131(3):880–889. doi:10.1378/chest.06-2063.
  • Cañete C, Galarza I, Granados A, Farrero E, Estopà R, Manresa F. Tuberculous pleural effusion: experience with six months of treatment with isoniazid and rifampicin. Thorax. 1994;49(11):1160–1161. doi:10.1136/thx.49.11.1160.
  • Lai YF, Chao TY, Wang YH, Lin AS. Pigtail drainage in the treatment of tuberculosis pleural effusions: a randomised study. Thorax. 2003;58(2):149–151. doi:10.1136/thorax.58.2.149.
  • Garcia-Rodriguez JF, Valcarce-Pardeiro N, Alvarez-Diaz H, Marino-Callejo A. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis. Eur J Clin Microbiol Infect Dis. 2019;38(11):2121–2126. doi:10.1007/s10096-019-03651-7.
  • Wyser C, Walzl G, Smedema JP, Swart F, van Schalkwyk EM, van de Wal BW. Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest. 1996;110(2):333–338. doi:10.1378/chest.110.2.333.
  • Ryan H, Yoo J, Darsini P. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. 2017;3:CD001876. doi:10.1002/14651858.CD001876.pub3.
  • Bhuniya S, Arunabha DC, Choudhury S, Saha I, Roy TS, Saha M. Role of therapeutic thoracentesis in tuberculosis pleural effusion. Ann Thorac Med. 2012;7(4):215–219. doi:10.4103/1817-1737.102176.
  • Light RW. Update on tuberculous pleural effusion. Respirology. 2010;15(3):451–458. doi:10.1111/j.1440-1843.2010.01723.x.
  • Ferrer J. Tuberculous pleural effusion and tuberculous empyema. Semin Respir Crit Care Med. 2001;22(6):637–646. doi:10.1055/s-2001-18800.
  • Long R, Barrie J, Stewart K, Peloquin CA. Treatment of a tuberculous empyema with simultaneous oral and intrapleural antituberculosis drugs. Can Respir J. 2008;15(5):241–243. doi:10.1155/2008/747206.
  • Cho J-K, Choi YM, Lee SS, et al. Clinical features and outcomes of abdominal tuberculosis in southeastern Korea: 12 years of experience. BMC Infect Dis. 2018;18(1):699. doi:10.1186/s12879-018-3635-2.
  • Debi U, Ravisankar V, Prasad KK, Sinha SK, Sharma AK. Abdominal tuberculosis of the gastrointestinal tract: revisited. World J Gastroenterol. 2014;20(40):14831–14840. doi:10.3748/wjg.v20.i40.14831.
  • Mukewar S, Mukewar S, Ravi R, Prasad A, S Dua K. Colon tuberculosis: endoscopic features and prospective endoscopic follow-up after anti-tuberculosis treatment. Clin Transl Gastroenterol. 2012;3:e24. doi:10.1038/ctg.2012.19.
  • Nagi B, Kochhar R, Bhasin DK, Singh K. Colorectal tuberculosis. Eur Radiol. 2003;13(8):1907–1912. doi:10.1007/s00330-002-1409-z.
  • Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn’s disease: a diagnostic challenge. Am J Gastroenterol. 2009;104(4):1003–1012. doi:10.1038/ajg.2008.162.
  • Jakubowski A, Elwood RK, Enarson DA. Clinical features of abdominal tuberculosis. J Infect Dis. Oct 1988;158(4):687–692. doi:10.1093/infdis/158.4.687.
  • Lee W-K, Van Tonder F, Tartaglia CJ, et al. CT appearances of abdominal tuberculosis. Clin Radiol. 2012;67(6):596–604. doi:10.1016/j.crad.2011.11.003.
  • Balthazar EJ, Gordon R, Hulnick D. Ileocecal tuberculosis: CT and radiologic evaluation. AJR Am J Roentgenol. 1990;154(3):499–503. doi:10.2214/ajr.154.3.2106212.
  • Pereira JM, Madureira AJ, Vieira A, Ramos I. Abdominal tuberculosis: imaging features. Eur J Radiol. 2005;55(2):173–180. doi:10.1016/j.ejrad.2005.04.015.
  • Gupta P, Kumar S, Sharma V, et al. Common and uncommon imaging features of abdominal tuberculosis. J Med Imaging Radiat Oncol. 2019;63(3):329–339. doi:10.1111/1754-9485.12874.
  • Pulimood AB, Ramakrishna BS, Kurian G, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis. Gut. 1999;45(4):537–541. doi:10.1136/gut.45.4.537.
  • Ye Z, Lin Y, Cao Q, He Y, Xue L. Granulomas as the Most Useful Histopathological Feature in Distinguishing between Crohn’s Disease and Intestinal Tuberculosis in Endoscopic Biopsy Specimens. Medicine (Baltimore). 2015;94(49):e2157. doi:10.1097/MD.0000000000002157.
  • Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45(1):27–36. doi:10.1111/apt.13840.
  • Patton PH, Parker CE, MacDonald JK, Chande N. Anti-tuberculous therapy for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2016;7:CD000299. doi:10.1002/14651858.CD000299.pub3.
  • Gupta A, Pratap Mouli V, Mohta S, et al. Anti-tubercular therapy given to differentiate Crohn’s disease from intestinal tuberculosis predisposes to stricture formation. J Crohns Colitis. 2020;14(11):1611–1618. doi:10.1093/ecco-jcc/jjaa091.
  • Marrie TJ, Hershfield ES. Tuberculosis peritonitis in Manitoba. Can J Surg. 1978;21(6):533–536.
  • Tirumani SH, Ojili V, Gunabushanam G, et al. Imaging of tuberculosis of the abdominal viscera: beyond the intestines. J Clin Imaging Sci. 2013;3:17. doi:10.4103/2156-7514.111234.
  • Sharma MP, Bhatia V. Abdominal tuberculosis. Indian J Med Res. 2004;120(4):305–315.
  • Abdelaal A, Alfkey R, Abdelaziem S, et al. Role of laparoscopic peritoneal biopsy in the diagnosis of peritoneal tuberculosis. A seven-year experience. Chirurgia (Bucur). 2014;109(3):330–334.
  • Yilmaz A, Ece F, Bayramgurler B, Akkaya E, Baran R. The value of Ca 125 in the evaluation of tuberculosis activity. Respir Med. 2001;95(8):666–669. doi:10.1053/rmed.2001.1121.
  • Jullien S, Jain S, Ryan H, Ahuja V. Six-month therapy for abdominal tuberculosis. Cochrane Database Syst Rev. 2016;11:CD012163. doi:10.1002/14651858.CD012163.pub2.
  • Park SH, Yang SK, Yang DH, et al. Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis. Antimicrob Agents Chemother. 2009;53(10):4167–4171. doi:10.1128/aac.00874-09.
  • Leonard MK, Blumberg HM. Musculoskeletal Tuberculosis. Microbiol Spectr. 2017;5(2). doi:10.1128/microbiolspec.TNMI7-0046-2017.
  • Sharma A, Chhabra HS, Chabra T, Mahajan R, Batra S, Sangondimath G. Demographics of tuberculosis of spine and factors affecting neurological improvement in patients suffering from tuberculosis of spine: a retrospective analysis of 312 cases. Spinal Cord. 2017;55(1):59–63. doi:10.1038/sc.2016.85.
  • Johansen IS, Nielsen SL, Hove M, et al. Characteristics and Clinical Outcome of Bone and Joint Tuberculosis From 1994 to 2011: A Retrospective Register-based Study in Denmark. Clin Infect Dis. 2015;61(4):554–562. doi:10.1093/cid/civ326.
  • Broderick C, Hopkins S, Mack DJF, et al. Delays in the diagnosis and treatment of bone and joint tuberculosis in the United Kingdom. Bone Joint J. 2018;100-B(1):119–124. doi:10.1302/0301-620x.100b1.Bjj-2017-0357.R1.
  • Singh R, Magu NK, Rohilla RK. Clinicoradiologic Profile of Involvement and Healing in Tuberculosis of the Spine. Ann Med Health Sci Res. 2016;6(5):311–327. doi:10.4103/amhsr.amhsr_188_15.
  • Dunn RN, Ben Husien M. Spinal tuberculosis: review of current management. Bone Joint J. 2018;100-B(4):425–431. doi:10.1302/0301-620x.100b4.Bjj-2017-1040.R1.
  • Boachie-Adjei O, Squillante RG. Tuberculosis of the spine. Orthop Clin North Am. 1996;27(1):95–103.
  • Rezai AR, Lee M, Cooper PR, Errico TJ, Koslow M. Modern management of spinal tuberculosis. Neurosurgery. 1995;36(1):87–97. doi:10.1227/00006123-199501000-00011.
  • Bhandari A, Garg RK, Malhotra HS, et al. Outcome assessment in conservatively managed patients with cervical spine tuberculosis. Spinal Cord. 2014;52(6):489–493. doi:10.1038/sc.2014.49.
  • Kim JH, Ahn JY, Jeong SJ, et al. Prognostic factors for unfavourable outcomes of patients with spinal tuberculosis in a country with an intermediate tuberculosis burden: a multicentre cohort study. Bone Joint J. 2019;101-B(12):1542–1549. doi:10.1302/0301-620x.101b12.Bjj-2019-0558.R1.
  • Kilborn T, Janse van Rensburg P, Candy S. Pediatric and adult spinal tuberculosis: imaging and pathophysiology. Neuroimaging Clin N Am. 2015;25(2):209–231. doi:10.1016/j.nic.2015.01.002.
  • Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR. Tuberculosis: a radiologic review. Radiographics. 2007;27(5):1255–1273. doi:10.1148/rg.275065176.
  • Boxer DI, Pratt C, Hine AL, McNicol M. Radiological features during and following treatment of spinal tuberculosis. Br J Radiol. 1992;65(774):476–479. doi:10.1259/0007-1285-65-774-476.
  • Joseffer SS, Cooper PR. Modern imaging of spinal tuberculosis. J Neurosurg Spine. 2005;2(2):145–150. doi:10.3171/spi.2005.2.2.0145.
  • Jain AK, Sreenivasan R, Mukunth R, Dhammi IK. Tubercular spondylitis in children. Indian J Orthop. 2014;48(2):136–144. doi:10.4103/0019-5413.128747.
  • Shikhare SN, Singh DR, Shimpi TR, Peh WC. Tuberculous osteomyelitis and spondylodiscitis. Semin Musculoskelet Radiol. 2011;15(5):446–458. doi:10.1055/s-0031-1293491.
  • Gu Y, Wang G, Dong W, et al. Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis. Int J Infect Dis. 2015;36:27–30. doi:10.1016/j.ijid.2015.05.014.
  • Held M, Laubscher M, Mears S, et al. Diagnostic Accuracy of the Xpert MTB/RIF Assay for Extrapulmonary Tuberculosis in Children With Musculoskeletal Infections. Pediatr Infect Dis J. 2016;35(11):1165–1168. doi:10.1097/INF.0000000000001271.
  • Held M, Laubscher M, Zar HJ, Dunn RN. GeneXpert polymerase chain reaction for spinal tuberculosis: an accurate and rapid diagnostic test. Bone Joint J. 2014;96-B(10):1366–1369. doi:10.1302/0301-620x.96b10.34048.
  • Shen Y, Yu G, Zhong F, Kong X. Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis. PLoS One. 2019;14(8):e0221427. doi:10.1371/journal.pone.0221427.
  • Cao G, Rao J, Cai Y, et al. Analysis of Treatment and Prognosis of 863 Patients with Spinal Tuberculosis in Guizhou Province. Biomed Res Int. 2018;2018:3265735. doi:10.1155/2018/3265735.
  • Wei G, Mu J, Wang G, et al. The reliability analysis of Xpert-positive result for smear-negative and culture-negative specimen collected from bone and joint tuberculosis suspects. J Thorac Dis. 2016;8(6):1205–1209. doi:10.21037/jtd.2016.04.19.
  • Faroug R, Psyllakis P, Gulati A, Makvana S, Pareek M, Mangwani J. Diagnosis and treatment of tuberculosis of the foot and ankle-A literature review. Foot (Edinb). 2018;37:105–112. doi:10.1016/j.foot.2018.07.005.
  • Barik S, Choudhury AK, Singh V, Bali S. Extra-Spinal Osteoarticular Tuberculosis: A Retrospective Analysis of 103 Cases. Curr Health Sci J. 2019;45(2):142–147. doi:10.12865/chsj.45.02.03.
  • Watts HG, Lifeso RM. Tuberculosis of bones and joints. J Bone Joint Surg Am. 1996;78(2):288–298. doi:10.2106/00004623-199602000-00019.
  • Hogan JI, Hurtado RM, Nelson SB. Mycobacterial Musculoskeletal Infections. Infect Dis Clin North Am. 2017;31(2):369–382. doi:10.1016/j.idc.2017.01.007.
  • Choi JA, Koh SH, Hong SH, Koh YH, Choi JY, Kang HS. Rheumatoid arthritis and tuberculosis arthritis: differentiating MRI features. AJR Am J Roentgenol. 2009;193(5):1347–1353. doi:10.2214/AJR.08.2164.
  • Sawlani V, Chandra T, Mishra RN, Aggarwal A, Jain UK, Gujral RB. MRI features of tuberculosis of peripheral joints. Clin Radiol. 2003;58(10):755–762. doi:10.1016/s0009-9260(03)00271-x.
  • Sanghvi DA, Iyer VR, Deshmukh T, Hoskote SS. MRI features of tuberculosis of the knee. Skeletal Radiol. 2009;38(3):267–273. doi:10.1007/s00256-008-0617-2.
  • Shu CC, Wang JY, Yu CJ, Lee LN. Mycobacterial arthritis of large joints. Ann Rheum Dis. 2009;68(9):1504–1505. doi:10.1136/ard.2008.095554.
  • Donald PR. The chemotherapy of osteo-articular tuberculosis with recommendations for treatment of children. J Infect. 2011;62(6):411–439. doi:10.1016/j.jinf.2011.04.239.
  • Controlled trial of short-course regimens of chemotherapy in the ambulatory treatment of spinal tuberculosis. Results at three years of a study in Korea. Twelfth report of the Medical Research Council Working Party on Tuberculosis of the Spine. J Bone Joint Surg Br. 1993;75(2):240–248. doi:10.1302/0301-620x.75b2.8444944.
  • A 15-year assessment of controlled trials of the management of tuberculosis of the spine in Korea and Hong Kong. Thirteenth Report of the Medical Research Council Working Party on Tuberculosis of the Spine. J Bone Joint Surg Br. 1998;80(3):456–462. doi:10.1302/0301-620x.80b3.8544.
  • Parthasarathy R, Sriram K, Santha T, Prabhakar R, Somasundaram PR, Sivasubramanian S. Short-course chemotherapy for tuberculosis of the spine. A comparison between ambulant treatment and radical surgery-ten-year report. J Bone Joint Surg Br. 1999;81(3):464–471. doi:10.1302/0301-620x.81b3.9043.
  • Jain AK, Sreenivasan R, Saini NS, Kumar S, Jain S, Dhammi IK. Magnetic resonance evaluation of tubercular lesion in spine. Int Orthop. 2012;36(2):261–269. doi:10.1007/s00264-011-1380-x.
  • Mittal S, Jain AK, Chakraborti KL, Aggarwal AN, Upreti L, Bhayana H. Evaluation of Healed Status in Tuberculosis of Spine by Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography and Contrast Magnetic Resonance Imaging. Indian J Orthop. 2019;53(1):160–168. doi:10.4103/ortho.IJOrtho_224_18.
  • Jutte PC, Van Loenhout-Rooyackers JH. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev. 2006;(1);Cd004532. doi:10.1002/14651858.CD004532.pub2.
  • Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–187. doi:10.1016/j.jinf.2009.06.011.
  • Leonard JM. Central Nervous System Tuberculosis. Microbiol Spectr. 2017;5(2). doi:10.1128/microbiolspec.TNMI7-0044-2017.
  • Arvanitakis Z, Long RL, Hershfield ES, et al. M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence. Neurology. 1998;50(6):1827–1832. doi:10.1212/WNL.50.6.1827.
  • Hsu PC, Yang CC, Ye JJ, Huang PY, Chiang PC, Lee MH. Prognostic factors of tuberculosis meningitis in adults: a 6-year retrospective study at a tertiary hospital in northern Taiwan. J Microbiol Immunol Infect. 2010;43(2):111–118. doi:10.1016/S1684-1182(10)60018-7.
  • Wilkinson RJ, Rohlwink U, Misra UK, Tuberculous Meningitis International Research Consortium, et al. Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581–598. doi:10.1038/nrneurol.2017.120.
  • Chiang SS, Khan FA, Milstein MB, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. Oct 2014;14(10):947–957. doi:10.1016/S1473-3099(14)70852-7.
  • Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741–1751. doi:10.1056/NEJMoa040573.
  • Torok ME, Nguyen DB, Tran TH, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One. 2011;6(12):e27821. doi:10.1371/journal.pone.0027821.
  • Erdem H, Ozturk-Engin D, Tireli H, et al. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol. 2015;262(4):890–898. doi:10.1007/s00415-015-7651-5.
  • Marais BJ, Heemskerk AD, Marais SS, Tuberculous Meningitis International Research Consortium, et al. Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies. Clin Infect Dis. 2017;64(4):501–509. doi:10.1093/cid/ciw757.
  • Thao LTP, Wolbers M, Heemskerk AD, et al. Dynamic Prediction of Death in Patients With Tuberculous Meningitis Using Time-updated Glasgow Coma Scale and Plasma Sodium Measurements. Clin Infect Dis. 2020;70(5):827–834. doi:10.1093/cid/ciz262.
  • Sanei Taheri M, Karimi MA, Haghighatkhah H, Pourghorban R, Samadian M, Delavar Kasmaei H. Central nervous system tuberculosis: an imaging-focused review of a reemerging disease. Radiol Res Pract. 2015;2015:202806. doi:10.1155/2015/202806.
  • Botha H, Ackerman C, Candy S, Carr JA, Griffith-Richards S, Bateman KJ. Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculosis meningitis. PLoS One. 2012;7(6):e38982. doi:10.1371/journal.pone.0038982.
  • Pienaar M, Andronikou S, van Toorn R. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst. 2009;25(8):941–947. doi:10.1007/s00381-008-0785-3.
  • Bourgi K, Fiske C, Sterling TR. Tuberculosis Meningitis. Curr Infect Dis Rep. 2017;19(11):39. doi:10.1007/s11908-017-0595-4.
  • Stewart SM. The bacteriological diagnosis of tuberculous meningitis. J Clin Pathol. 1953;6(3):241–242. doi:10.1136/jcp.6.3.241.
  • Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA. 1979;241(3):264–268.
  • Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio. 2017;8(4). doi:10.1128/mBio.00812-17.
  • World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extra-Pulmonary TB in Adults and Children. Policy Update. Geneva: World Health Organization. 2013.
  • World Health Organization. WHO meeting report of a technical expert consultation: non-inferiority analysis of Xpert MTF/RIF Ultra compared to Xpert MTB/RIF. Geneva: World Health Organization. 2017. https://apps.who.int/iris/handle/10665/254792. License: CC BY-NC-SA 3.0 IGO. Accessed March 2, 2022.
  • Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993;17(6):987–994. doi:10.1093/clinids/17.6.987.
  • Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J. Tuberculous meningitis. J Neurol Neurosurg Psychiatry. 2000;68(3):289–299. doi:10.1136/jnnp.68.3.289.
  • Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21(2):243–261, table of contents. doi:10.1128/CMR.00042-07.
  • Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147–e195. doi:10.1093/cid/ciw376.
  • National Institute for Health and Care Excellence. Tuberculosis [NICE Guideline No. 33]. November 13, 2020. https://www.nice.org.uk/guidance/ng33. Accessed November 13, 2020.
  • American Academy of Pediatrics. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018.
  • World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. World Health Organization; 2017. https://apps.who.int/iris/handle/10665/255052. Accessed March 2, 2022.
  • World Health Organization. Treatment of Tuberculosis: guidelines. 4th ed. Geneva: World Health Organization; 2010. https://apps.who.int/iris/handle/10665/44165. Accessed on March 2, 2022.
  • Cresswell FV, Te Brake L, Atherton R, et al. Intensified antibiotic treatment of tuberculosis meningitis. Expert Rev Clin Pharmacol. 2019;12(3):267–288. doi:10.1080/17512433.2019.1552831.
  • ClinicalTrials.gov [Internet]. Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculosis Meningitis (INTENSE-TBM). National Library of Medicine (US). Updated August 28, 2020. Accessed September 28, 2020. https://clinicaltrials.gov/ct2/show/NCT04145258.
  • Marais S, Cresswell FV, Hamers RL, et al. High dose oral rifampicin to improve survival from adult tuberculosis meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study). Wellcome Open Research. 2019;4.190. doi:10.12688/wellcomeopenres.15565.1.
  • ClinicalTrials.gov [Internet]. Optimizing Treatment to Improve TBM Outcomes in Children (TBM-KIDS). National Library of Medicine (US). Sept 28, 2020. Updated Aug 13, 2020. https://clinicaltrials.gov/ct2/show/NCT02958709. Accessed September 29, 2020.
  • Charlie L, Abay SM, Tesfaye A, Mlera RN, Mwango S, Goretti M. Safety and efficacy of high-dose rifampicin in the management of tuberculosis meningitis: Systematic review and meta-analysis. Int J Mycobacteriol. 2021;10(3):312–319. doi:10.4103/ijmy.ijmy_135_21.
  • Cresswell FV, Meya DB, Kagimu E, et al. High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculosis Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial. Clin Infect Dis. 2021;73(5):876–884. doi:10.1093/cid/ciab162.
  • Wasserman S, Davis A, Stek C, et al. Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial. Antimicrob Agents Chemother. 2021;65(8):e0014021. doi:10.1128/AAC.00140-21.
  • Svensson EM, Dian S, Te Brake L, et al. Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials. Clin Infect Dis. 2020;71(8):1817–1823. Nov 5doi:10.1093/cid/ciz1071.
  • Arbiv. Thorax. 2022.
  • Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis. 1993;148(3):650–655. doi:10.1164/ajrccm/148.3.650.
  • Rizvi I, Malhotra HS, Garg RK, Kumar N, Uniyal R, Pandey S. Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis. J Infect. 2018;77(4):261–275. doi:10.1016/j.jinf.2018.06.009.
  • Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculosis meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013;13(1):27–35. doi:10.1016/S1473-3099(12)70264-5.
  • Heemskerk AD, Bang ND, Mai NT, et al. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. N Engl J Med. 2016;374(2):124–134. doi:10.1056/NEJMoa1507062.
  • Heemskerk AD, Nguyen MTH, Dang HTM, et al. Clinical Outcomes of Patients With Drug-Resistant Tuberculosis Meningitis Treated With an Intensified Antituberculosis Regimen. Clin Infect Dis. 2017;65(1):20–28. doi:10.1093/cid/cix230.
  • Sun F, Ruan Q, Wang J, et al. Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis. Antimicrob Agents Chemother. 2014;58(10):6297–6301. doi:10.1128/AAC.02784-14.
  • Li H, Lu J, Liu J, Zhao Y, Ni X, Zhao S. Linezolid is Associated with Improved Early Outcomes of Childhood Tuberculosis Meningitis. Pediatr Infect Dis J. 2016;35(6):607–610. doi:10.1097/INF.0000000000001114.
  • Alvarez-Uria G, Midde M, Pakam R, Naik PK. Initial Antituberculous Regimen with Better Drug Penetration into Cerebrospinal Fluid Reduces Mortality in HIV Infected Patients with Tuberculous Meningitis: Data from an HIV Observational Cohort Study. Tuberc Res Treat. 2013;2013:242604. doi:10.1155/2013/242604.
  • Donald PR, Schoeman JF, Van Zyl LE, De Villiers JN, Pretorius M, Springer P. Intensive short course chemotherapy in the management of tuberculosis meningitis. Int J Tuberc Lung Dis. 1998;2(9):704–711.
  • Jullien S, Ryan H, Modi M, Bhatia R. Six months therapy for tuberculous meningitis. Cochrane Database Syst Rev. 2016;9:CD012091. doi:10.1002/14651858.CD012091.pub2.
  • World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. 2017. Licence: CC BY-NC-SA 3.0 IGO.
  • Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147–e195. doi:10.1093/cid/ciw376.
  • Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. doi:10.1002/14651858.CD002244.pub4.
  • Donovan J, Thwaites GE, Huynh J. Tuberculosis meningitis: where to from here? Curr Opin Infect Dis. 2020;33(3):259–266. doi:10.1097/QCO.0000000000000648.
  • Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P. The role of aspirin in childhood tuberculous meningitis. J Child Neurol. 2011;26(8):956–962. doi:10.1177/0883073811398132.
  • Mai NT, Dobbs N, Phu NH, et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculosis meningitis in HIV-uninfected adults. eLife. 2018;7:e33478. doi:10.7554/eLife.33478.
  • ClinicalTrials.gov [Internet]. Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM (LASER-TBM). National Library of Medicine (US). Sept 28 2020. Updated August 14, 2020. https://clinicaltrials.gov/ct2/show/NCT03927313.
  • ISRCTN registry [Internet]. SURE: Short intensive treatment for children with tuberculosis meningitis. BMC. September, 28, 2020. Updated Sept 23, 2020. doi:10.1186/ISRCTN40829906.
  • Rohlwink UK, Kilborn T, Wieselthaler N, Banderker E, Zwane E, Figaji AA. Imaging Features of the Brain, Cerebral Vessels and Spine in Pediatric Tuberculous Meningitis With Associated Hydrocephalus. Pediatr Infect Dis J. Oct 2016;35(10):e301–e310. doi:10.1097/INF.0000000000001236.
  • Marais S, Van Toorn R, Chow FC, Tuberculous Meningitis International Research Consortium, et al. Management of intracranial tuberculous mass lesions: how long should we treat for? Wellcome Open Res. 2019;4:158. doi:10.12688/wellcomeopenres.15501.2.
  • Donovan J, Figaji A, Imran D, Phu NH, Rohlwink U, Thwaites GE. The neurocritical care of tuberculosis meningitis. Lancet Neurol. 2019;18(8):771–783. doi:10.1016/S1474-4422(19)30154-1.
  • Crump JA, Reller LB. Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture. Clin Infect Dis. 2003;37(8):1037–1043. Oct 15doi:10.1086/378273.
  • Meira L, Chaves C, Araujo D, et al. Predictors and outcomes of disseminated tuberculosis in an intermediate burden setting. Pulmonology. 2019;25(6):320–327. doi:10.1016/j.pulmoe.2018.11.001.
  • Lee J, Lim JK, Kim EJ, et al. Comparison of clinical manifestations and treatment outcome according to age groups in adult patients with miliary tuberculosis. J Thorac Dis. 2018;10(5):2881–2889. doi:10.21037/jtd.2018.04.139.
  • Mohan A, Sharma SK, Pande JN. Acute respiratory distress syndrome (ARDS) in miliary tuberculosis: a twelve year experience. Indian J Chest Dis Allied Sci. 1996;38(3):157–162.
  • Boushab BM, Basco LK. Miliary tuberculosis and acute respiratory distress syndrome. J Clin Tuberc Other Mycobact Dis. 2019;16:100113. doi:10.1016/j.jctube.2019.100113.
  • Long R, O’Connor R, Palayew M, Hershfield E, Manfreda J. Disseminated tuberculosis with and without a miliary pattern on chest radiograph: a clinical-pathologic-radiologic correlation. Int J Tuberc Lung Dis. 1997;1(1):52–58.
  • Sharma SK, Mohan A, Sharma A. Miliary tuberculosis: A new look at an old foe. J Clin Tuberc Other Mycobact Dis. 2016;3:13–27. doi:10.1016/j.jctube.2016.03.003.
  • Heiden D, Saranchuk P, Keenan JD, et al. Eye examination for early diagnosis of disseminated tuberculosis in patients with AIDS. Lancet Infect Dis. 2016;16(4):493–499. doi:10.1016/S1473-3099(15)00269-8.
  • Mehta S. Patterns of ocular inflammation in patients with miliary tuberculosis. F1000Res. 2017;6:412. doi:10.12688/f1000research.11035.1.
  • Rieder HL, Kelly GD, Bloch AB, Cauthen GM, Snider DE.Jr. Tuberculosis diagnosed at death in the United States. Chest. 1991;100(3):678–681. doi:10.1378/chest.100.3.678.
  • Optican RJ, Ost A, Ravin CE. High-resolution computed tomography in the diagnosis of miliary tuberculosis. Chest. 1992;102(3):941–943. doi:10.1378/chest.102.3.941.
  • Lefebvre N, Argemi X, Meyer N, et al. Clinical usefulness of 18F-FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis. Nucl Med Biol. 2017;50:17–24. doi:10.1016/j.nucmedbio.2017.04.003.
  • Abbara A, Davidson RN, Etiology and management of genitourinary tuberculosis. Nat Rev Urol. 2011;8(12):678–688. doi:10.1038/nrurol.2011.172.
  • Fanning A. Tuberculosis: 6. Extrapulmonary disease. CMAJ. 1999;160(11):1597–1603.
  • Sourial MW, Brimo F, Horn R, Andonian S. Genitourinary tuberculosis in North America: A rare clinical entity. Can Urol Assoc J. 2015;9(7-8):E484–9. doi:10.5489/cuaj.2643.
  • Cao Y, Fan Y, Chen Y, et al. Gross Hematuria Is More Common in Male and Older Patients with Renal Tuberculosis in China: A Single-Center 15-Year Clinical Experience. Urol Int. 2017;99(3):290–296. doi:10.1159/000464472.
  • Eastwood JB, Corbishley CM, Grange JM. Tuberculosis and the kidney. J Am Soc Nephrol. 2001;12(6):1307–1314. doi:10.1681/ASN.V1261307.
  • Merchant S, Bharati A, Merchant N. Tuberculosis of the genitourinary system-Urinary tract tuberculosis: Renal tuberculosis-Part II. Indian J Radiol Imaging. 2013;23(1):64–77. doi:10.4103/0971-3026.113617.
  • Maclean KA, Becker AK, Chang SD, Harris AC. Extrapulmonary tuberculosis: imaging features beyond the chest. Can Assoc Radiol J. 2013;64(4):319–324. doi:10.1016/j.carj.2012.07.002.
  • Wang Y, Wu JP, Qin GC, et al. Computerised tomography and intravenous pyelography in urinary tuberculosis: a retrospective descriptive study. Int J Tuberc Lung Dis. 2015;19(12):1441–1447. doi:10.5588/ijtld.14.0888.
  • Webster D, Long R, Shandro C, et al. Fluoroquinolone resistance among renal tuberculosis isolates in Alberta Canada;1990-2003. International Journal of Tuberculosis and Lung Disease. 2010;14:217–222.
  • Goldfarb DS. SL. Tuberculosis of the genitourinary tract. 1996. 609–622. Tuberculosis.
  • Grace GA, Devaleenal DB, Natrajan M. Genital tuberculosis in females. Indian J Med Res. 2017;145(4):425–436. doi:10.4103/ijmr.IJMR_1550_15.
  • Sharma JB, Sharma E, Sharma S, Dharmendra S. Female genital tuberculosis: Revisited. Indian J Med Res. 2018;148(Suppl):S71–s83. Decdoi:10.4103/ijmr.IJMR_648_18.
  • Gupta B, Shree S, Rajaram S, Goel N. Genital tuberculosis: Unusual presentations. Int J Mycobacteriol. 2016;5(3):357–359. doi:10.1016/j.ijmyco.2016.06.017.
  • Khanna A, Agrawal A. Markers of genital tuberculosis in infertility. Singapore Med J. 2011;52(12):864–867.
  • Shah HU, Sannananja B, Baheti AD, Udare AS, Badhe PV. Hysterosalpingography and ultrasonography findings of female genital tuberculosis. Diagn Interv Radiol. 2015;21(1):10–15. doi:10.5152/dir.2014.13517.
  • Sharma JB, Roy KK, Pushparaj M, Kumar S, Malhotra N, Mittal S. Laparoscopic findings in female genital tuberculosis. Arch Gynecol Obstet. 2008;278(4):359–364. doi:10.1007/s00404-008-0586-7.
  • Kumar P, Shah NP, Singhal A, et al. Association of tuberculous endometritis with infertility and other gynecological complaints of women in India. J Clin Microbiol. 2008;46(12):4068–4070. doi:10.1128/jcm.01162-08.
  • Neelam BM. Namita K. Genital tuberculosis and its consequences on subsequent fertility. J Obstet Gynecol India. 2005; 2005(6):534–537.
  • Flibotte JJ, Lee GE, Buser GL, et al. Infertility, in vitro fertilization and congenital tuberculosis. J Perinatol. 2013;33(7):565–568. doi:10.1038/jp.2012.146.
  • Yadav S, Singh P, Hemal A, Kumar R. Genital tuberculosis: current status of diagnosis and management. Transl Androl Urol. 2017;6(2):222–233. doi:10.21037/tau.2016.12.04.
  • Aziz EM, Abdelhak K, Hassan FM. Tuberculous prostatitis: mimicking a cancer. Pan Afr Med J. 2016;25:130 doi:10.11604/pamj.2016.25.130.7577.
  • Gonzalez OY, Musher DM, Brar I, et al. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis. 2003;36(2):140–148. doi:10.1086/344908.
  • Kim S, Wise G, Schleel P, Khani F, Herr H. Adverse Effects of Intravesical bacillus Calmette-Guerin Therap. AUA Update Series. 2018;37(Lesson 8)
  • Lamm DL. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Clin Infect Dis. 2000;31 Suppl 3:S86–S90. doi:10.1086/314064.
  • Larsen ES, Nordholm AC, Lillebaek T, Holden IK, Johansen IS. The epidemiology of bacille Calmette-Guérin infections after bladder instillation from 2002 through 2017: a nationwide retrospective cohort study. BJU Int. 2019;124(6):910–916. doi:10.1111/bju.14793.
  • Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, et al. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore). 2014;93(17):236–254. doi:10.1097/MD.0000000000000119.
  • Marques M, Vazquez D, Sousa S, Mesquita G, Duarte M, Ferreira R. Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A Case Report and Narrative Review. Pulmonology. 2020;26(6):346–352. doi:10.1016/j.pulmoe.2019.10.001.
  • Waked R, Choucair J, Chehata N, Haddad E, Saliba G. Intravesical Bacillus Calmette-Guérin (BCG) treatment’s severe complications: A single institution review of incidence, presentation and treatment outcome. J Clin Tuberc Other Mycobact Dis. 2020;19:100149. doi:10.1016/j.jctube.2020.100149.
  • Cek M, Lenk S, Naber KG, Members of the Urinary Tract Infection (UTI) Working Group of the European Association of Urology (EAU) Guidelines Office, et al. EAU guidelines for the management of genitourinary tuberculosis. Eur Urol. 2005;48(3):353–362. doi:10.1016/j.eururo.2005.03.008.
  • Gow JG. Genitourinary tuberculosis: a 7-year review. Br J Urol. 1979;51(4):239–244. doi:10.1111/j.1464-410x.1979.tb04700.x.
  • Migliori GB, Sotgiu G, Rosales-Klintz S, et al. ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update. Eur Respir J. 2018;51(5):1702678. doi:10.1183/13993003.02678-2017.
  • Sharma JB, Singh N, Dharmendra S, et al. Six months versus nine months anti-tuberculous therapy for female genital tuberculosis: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;203:264–273. doi:10.1016/j.ejogrb.2016.05.035.
  • Syed FF, Mayosi BM. A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis. 2007;50(3):218–236. doi:10.1016/j.pcad.2007.03.002.
  • Cherian G, Habashy AG, Uthaman B, Cherian JM, Salama A, Anim JT. Detection and follow-up of mediastinal lymph node enlargement in tuberculous pericardial effusions using computed tomography. Am J Med. 2003;114(4):319–322. doi:10.1016/s0002-9343(02)01521-8.
  • Sun JS, Park KJ, Kang DK. CT findings in patients with pericardial effusion: differentiation of malignant and benign disease. AJR Am J Roentgenol. 2010;194(6):W489–94. doi:10.2214/AJR.09.2599.
  • Agner RC, Gallis HA. Pericarditis: differential diagnostic considerations. Arch Intern Med. 1979;139(4):407–412. doi:10.1001/archinte.139.4.407.
  • Wiysonge CS, Ntsekhe M, Thabane L, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. 2017;9:CD000526. doi:10.1002/14651858.CD000526.pub2.
  • Reuter H, Burgess LJ, Schneider J, Van Vuuren W, Doubell AF. The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV. Histopathology. 2006;48(3):295–302. doi:10.1111/j.1365-2559.2005.02320.x.
  • Tuon FF, Litvoc MN, Lopes MI. Adenosine deaminase and tuberculous pericarditis-a systematic review with meta-analysis. Acta Trop. 2006;99(1):67–74. doi:10.1016/j.actatropica.2006.07.004.
  • Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculosis constrictive pericarditis in Transkei. Lancet. 1987;2(8573):1418–1422. doi:10.1016/S0140-6736(87)91127-5.
  • Reuter H, Burgess LJ, Louw VJ, Doubell AF. The management of tuberculosis pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr. 2007;18(1):20–25.
  • Mayosi BM, Ntsekhe M, Bosch J, IMPI Trial Investigators, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371(12):1121–1130. doi:10.1056/NEJMoa1407380.
  • Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):14–24. doi:10.3109/09273948.2014.986582.
  • Conant MM, Vrasich CR, Wongskhaluang JV, et al. Role of the Infectious Disease Consultant in Management of Patients With Tuberculosis-Associated Ocular Inflammation. Open Forum Infect Dis. 2016;3(1):ofv195. doi:10.1093/ofid/ofv195.
  • Patel SS, Saraiya NV, Tessler HH, Goldstein DA. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol. 2013;131(6):752–758. doi:10.1001/jamaophthalmol.2013.71.
  • Lynn WA, Lightman S. The eye in systemic infection. Lancet. 2004;364(9443):1439–1450. doi:10.1016/S0140-6736(04)17228-0.
  • Cunningham ET, Jr., Rathinam SR, Albini TA, Chee SP, Zierhut M. Tuberculous uveitis. Ocul Immunol Inflamm. 2015;23(1):2–6. doi:10.3109/09273948.2014.1004016.
  • Arora SK, Gupta V, Gupta A, Bambery P, Kapoor GS, Sehgal S. Diagnostic efficacy of polymerase chain reaction in granulomatous uveitis. Tuber Lung Dis. 1999;79(4):229–233. doi:10.1054/tuld.1999.0210.
  • Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116(7):1391–1396. doi:10.1016/j.ophtha.2009.02.005.
  • Trad S, Bodaghi B, Saadoun D. Update on Immunological Test (Quantiferon-TB Gold) Contribution in the Management of Tuberculosis-Related Ocular Inflammation. Ocul Immunol Inflamm. 2018;26(8):1192–1199. doi:10.1080/09273948.2017.1332232.
  • Lee C, Agrawal R, Pavesio C. Ocular Tuberculosis-A Clinical Conundrum. Ocul Immunol Inflamm. 2016;24(2):237–242. doi:10.3109/09273948.2014.985387.
  • Figueira L, Fonseca S, Ladeira I, Duarte R. Ocular tuberculosis: Position paper on diagnosis and treatment management. Rev Port Pneumol (2006). 2017;23(1):31–38. doi:10.1016/j.rppnen.2016.10.004.
  • Alvarez GG, Roth VR, Hodge W. Ocular tuberculosis: diagnostic and treatment challenges. Int J Infect Dis. 2009;13(4):432–435. doi:10.1016/j.ijid.2008.09.018.
  • Gan WL, Jones NP. Serpiginous-like choroiditis as a marker for tuberculosis in a non-endemic area. Br J Ophthalmol. 2013;97(5):644–647. doi:10.1136/bjophthalmol-2012-302918.
  • Ang M, Hedayatfar A, Wong W, Chee SP. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol. 2012;96(3):332–336. doi:10.1136/bjophthalmol-2011-300209.
  • Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146(5):772–779. doi:10.1016/j.ajo.2008.06.011.
  • Agrawal R, Gupta B, Gonzalez-Lopez JJ, et al. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):40–46. doi:10.3109/09273948.2014.986584.
  • Sanghvi C, Bell C, Woodhead M, Hardy C, Jones N. Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye (Lond). 2011;25(4):475–480. doi:10.1038/eye.2010.235.
  • Lou SM, Montgomery PA, Larkin KL, Winthrop K, Zierhut M, Rosenbaum JT, Uveitis Specialists Study Group Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm. 2015;23(1):32–39. doi:10.3109/09273948.2014.994784.
  • Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358–362. doi:10.1016/j.kjms.2015.05.004.
  • van Zyl L, Du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015;95(6):629–638. doi:10.1016/j.tube.2014.12.006.
  • Chen Q, Chen W, Hao F. Cutaneous tuberculosis: A great imitator. Clin Dermatol. 2019;37(3):192–199. doi:10.1016/j.clindermatol.2019.01.008.
  • Burgin S, Pomeranz MK, Orbuch P, et al. Mycobacteria and the skin. In: Rom WN, Garay S, eds. Tuberculosis. Toronto: Little, Brown and Company; 2004;593–608.
  • Delaval L, Goulenok T, Achouh P, et al. New insights on tuberculous aortitis. J Vasc Surg. 2017;66(1):209–215. doi:10.1016/j.jvs.2016.11.045.
  • Liu A, Nicol E, Hu Y, Coates A. Tuberculous endocarditis. Int J Cardiol. 2013;167(3):640–645. doi:10.1016/j.ijcard.2012.08.009.
  • Hakawi AM, Alrajhi AA. Tuberculosis of the bone marrow: clinico-pathological study of 22 cases from Saudi Arabia. Int J Tuberc Lung Dis. 2006;10(9):1041–1044.
  • Long R, Guzman R, Greenberg H, Safneck J, Hershfield E. Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest. 1999;115(2):522–531. doi:10.1378/chest.115.2.522.
  • Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Experience with ARDS caused by tuberculosis in a respiratory intensive care unit. Intensive Care Med. 2005;31(9):1284–1287. doi:10.1007/s00134-005-2721-2.
  • Lerolle N, Laanani M, Galicier L, et al. Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study. Int j Tuberc Lung Dis. 2020;24(1):124–130. doi:10.5588/ijtld.19.0856.
  • Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J. 1991;10(3):179–183. doi:10.1097/00006454-199103000-00002.
  • Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 1997;99(2):226–231. doi:10.1542/peds.99.2.226.
  • Dutt AK, Moers D, Stead WW. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years’ experience. Ann Intern Med. 1986;104(1):7–12. doi:10.7326/0003-4819-104-1-7.
  • Ramachandran S, Clifton IJ, Collyns TA, Watson JP, Pearson SB. The treatment of spinal tuberculosis: a retrospective study. Int J Tuberc Lung Dis. 2005;9(5):541–544.
  • Dian S, Yunivita V, Ganiem AR, et al. Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculosis Meningitis. Antimicrob Agents Chemother. 2018;62(12). doi:10.1128/AAC.01014-18.
  • Yunivita V, Dian S, Ganiem AR, et al. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients. Int J Antimicrob Agents. 2016;48(4):415–421. doi:10.1016/j.ijantimicag.2016.06.016.
  • Skutil V, Varsa J, Obsitník M. Six-month chemotherapy for urogenital tuberculosis. Eur Urol. 1985;11(3):170–176. doi:10.1159/000472484.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.